Jürgen Conrad

• Supporting life science companies to obtain national or international (European Union) grants to perform R&D projects
• Project management of European projects
• Identification of collaboration partners for European projects
• Start up financing of life science companies

Jürgen Conrad (PhD), is founder and managing director of ConsulTech GmbH. He has more than 25 years experience in life science industry. The projects which received public grants showed a broad range of subjects from nano materials for dental applications, oncology, neurology, infectious diseases, heart valves to molecular imaging and IVD.

ConsulTech published several studies and articles about German biotech industry and public funding of companies.

During his time with Schering AG Jürgen Conrad filed numerous patents in diagnostic imaging and is also inventor of Primovist® (Bayer). Primovist® is an innovative liver-specific contrast agent for MRI that significantly improves both detection and characterization of focal liver lesion.

More than 25 years experience in public funding programmes and more than 20 years experience in financing of start up companies in life sciences.

Education:

Biology (Diploma) Johannes-Gutenberg-University Mainz (Germany)
PhD in Molecular Biology Institute for Physiological Chemistry, Johannes-Gutenberg-University Mainz (Germany)

Experience:

R&D Project manager Molecular Imaging (Schering AG)
Managing Director R&D (Institut für Diagnostikforschung GmbH)
Managing Director (ConsulTech GmbH)

Areas of Expertise:

Public Funding of R&D

Grant Applications:

• More than 400 national grant applications in Germany
• More than € 500 mio. national and international grants
• FP4 BRITE-EURAM
• FP7 Health program
• FP7 ICT program
• EUROSTARS
• FP7 KBBE program

EU Project Manager

• www.eurocalin-fp7.eu
• www.miracle-fp7.eu

Customers

• Bayer AG
• Veridex LLC
• UCB S.A.
• Siemens AG
• Biotest AG
• Schering AG